MOVN, the virtual cardiac rehab platform created by Nueterra Capital portfolio company Moving Analytics, is being tested by the Allegheny Health Network, with a goal of demonstrating “higher adherence rates, tangible benefits like better well-being and stress management, and less hospitalization,” said Srinivas Murali, MD, chair of the Allegheny Health Network (AHN) Department of Cardiovascular Medicine and co-chair of the AHN Cardiovascular Institute. You can read the full interview with Dr. Murali and learn more about the benefits of virtual cardiac rehab here.
Dr. Yael Katz, the co-founder and CEO of Nueterra Capital portfolio company BrainCheck, was featured on the latest episode of the Passionate Pioneers podcast. Hosted by Mike Biselli, Passionate Pioneers highlights innovators, game changers, and pioneers who are deeply passionate and relentless in solving the problems that the world is facing. In this episode, Dr. Katz discusses her BrainCheck founding journey with BrainCheck, how the company is helping partners and patients during the COVID-19 pandemic, and where she sees cognitive health heading in the future. You can listen to the full episode here.
Kaitlyn Doyle, CEO of TheraWe, a Nueterra Capital portfolio company bridging the gap between pediatric therapy centers and the home, was featured on the most recent episode of “Rounding the Bases.” Hosted by keynote speaker and Kansas City Royals broadcaster Joel Goldberg, “Rounding the Bases” connects with successful entrepreneurs and leaders to compare the winning traits of sports to business. You can listen to (and watch) the full episode here.
The recent Advisory Board article “How virtual cardiac rehab can fill the Covid-19 treatment gap” cites Nueterra Capital portfolio company Moving Analytics as an example of how virtual cardiac rehab can help cardiac patients improve their outcomes and reduce readmissions even amidst Covid-19. Advisory Board noted that Moving Analytics‘ program has a 60% patient enrollment rate, which is significantly higher than the 24% enrollment rate for traditional rehab. You can read the full article here.
Nueterra Capital portfolio company Sickweather now includes a COVID-19 Score in its app. Similar to the company’s SickScore, the COVID-19 Score indicates the risk factor for illness in a particular city. Users can research the risk for their own locations, as well as those of their friends and families. They can also report COVID-19 cases within the app itself. Read more about Sickweather’s COVID-19 score in Startland News.
Sarah Hill, founder of Nueterra Capital portfolio company Healium, was in Nashville with her team when the tornado hit. They saw an immediate need for Healium’s anxiety-reducing virtual reality platform, and they delivered. You can read the full story in Startland News.
Nueterra Capital portfolio company Sickweather has issued a warning that flu-like symptoms and respiratory illness will continue through the spring and summer months. Sickweather’s analysis, based on real-time data, is in stark contrast to the traditional school of thought that flu-like symptoms tend to subside toward the end of March. You can read the full article here.
Software solutions company HST Pathways announced it will provide free access to Casetabs’ Schedule Sharing feature for its ambulatory surgery center (ASC) customers. Casetabs, a Nueterra Capital portfolio company, uses an intuitive central coordination hub to deliver real-time case information and updates to physicians, anesthesiologists, facility staff, physician office staff, and vendor reps. Casetabs’ Schedule Sharing feature allows referring practices and physicians to view schedules through a mobile app or desktop website, instead of relying on faxes or emails. You can read the full press release here.
Nueterra Capital portfolio company CareSignal (formerly Epharmix) recently announced it has raised total capital of $7 million from four investors: Nueterra Capital, UnityPoint Health Ventures, 1984 Ventures, and existing investor OSF Ventures. CareSignal’s scalable remote patient monitoring platform improves payor and provider performance in value-based care by prioritizing rising-risk patients in real-time. You can read more about CareSignal’s capital raise here.
Nueterra Capital portfolio company Epharmix announced that it has rebranded to CareSignalTM, to better convey its complete — and growing — suite of patient engagement software and services. You can read more about the company’s growth here.